As mentioned before, selective activation of FXR in the intestine protects mice against cholestasis by activation of FGF15 (mouse orthologue of FGF19) via a negative feedback loop to hepatic bile acid synthesis [65]. The gene discussed is NR1H4; the disease is cholestasis.